Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable targets and biomarkers in clinical practice. Novel biomarkers and tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuanzhao, Li, Zeyan, Liang, Meihua, Zhang, Ziyang, Zhu, Di, Lin, Biyun, Zhou, Renyu, Lu, Yuanzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311827/
https://www.ncbi.nlm.nih.gov/pubmed/37391802
http://dx.doi.org/10.1186/s12957-023-03078-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311827/
https://www.ncbi.nlm.nih.gov/pubmed/37391802
http://dx.doi.org/10.1186/s12957-023-03078-7

Ejemplares similares